| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/18/2013 | EP2674166A1 Use of erythropoietin (EPO) for the local treatment of cancer treatment-associated osteo-necrosis of the jaw |
| 12/18/2013 | EP2674165A2 Hepatocyte growth factor receptor agonist for increasing lymphangiogenesis |
| 12/18/2013 | EP2674156A1 Inhibitors of phosphatidic acid phosphohydrolase (pap), including d-propranolol and analogs thereof, alone or in combination with desipramine, for the treatment of cancers that depend on the epidermal growth factor receptor (egfr), oncogenic variants thereof and other members of the erbb/her family |
| 12/18/2013 | EP2673362A1 B-type plexin antagonists and uses thereof |
| 12/18/2013 | EP2673298A1 Anti-gb3 antibodies useful in treating disorders associated with angiogenesis |
| 12/18/2013 | EP2673295A1 Hexapeptide with improved activity in the repair of cellular dna of dermal cells |
| 12/18/2013 | EP2673287A1 Amino statin derivatives for the treatment of arthrosis |
| 12/18/2013 | EP2673277A1 [1, 2, 4]triazolo [4, 3 -b]pyridazine compounds as inhibitors of the c-met tyrosine kinase |
| 12/18/2013 | EP2673268A1 Method of inhibiting hamartoma tumor cells |
| 12/18/2013 | EP2673262A1 Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds |
| 12/18/2013 | EP2673250A2 Stilbene analogs and methods of treating cancer |
| 12/18/2013 | EP2672999A2 Improved immunotherapy |
| 12/18/2013 | EP2672969A1 Combination |
| 12/18/2013 | EP2496576B1 Imidazo[4,5-c]quinoline derivatives as bromodomain inhibitors |
| 12/18/2013 | EP2496557B1 Tetrahydroquinoline derivatives and their pharmaceutical use |
| 12/18/2013 | EP2438048B1 Polycyclic antagonists of lysophosphatidic acid receptors |
| 12/18/2013 | EP2392574B1 Indolyl pyrrolidines for the treatment of cancer |
| 12/18/2013 | EP2374807B1 An improved process for the isolation of temozolomide |
| 12/18/2013 | EP2344528B1 Pharmaceutical being used for treating cancer and fibrosis disease and the composition and uses thereof |
| 12/18/2013 | EP2274018B1 Modified hydroxypolymer conjugates with bone-seeking and tumor-killing moieties |
| 12/18/2013 | EP2254570B1 Combination comprising paclitaxel for treating ovarian cancer |
| 12/18/2013 | EP2197918B1 Combination therapy with type i and type ii anti-cd20 antibodies |
| 12/18/2013 | EP2165715B1 Therapeutic agent for cancer, and method for treatment of cancer |
| 12/18/2013 | EP2150539B1 Pyridazinone derivatives |
| 12/18/2013 | EP2057193B1 Ephb3-specific antibody and uses thereof |
| 12/18/2013 | EP2020410B1 Pyrido[2,3-d]pyrimidine derivatives, process for their preparation and their therapeutical use |
| 12/18/2013 | EP2020237B1 Ceramide and chemotherapeutic agents for inducing cell death |
| 12/18/2013 | EP2007370B1 Novel composition for tumor growth control |
| 12/18/2013 | EP1932541B1 Apoptosis promoter, cell proliferation inhibitor, prophylactic/therapeutic agent for cancer, screening method for the promoter, inhibitor or agent |
| 12/18/2013 | EP1782800B1 Methods for detecting JAK3 inhibitors |
| 12/18/2013 | EP1656952B1 Polyalkylene glycol conjugates of interferon beta-1A and uses thereof |
| 12/18/2013 | EP1523991B1 Anti-cancer vaccine |
| 12/18/2013 | CN103459595A Antibody against human prostaglandin E2 receptor EP4 |
| 12/18/2013 | CN103459425A Means and methods for treating DLBCL |
| 12/18/2013 | CN103459400A Novel imidazo-oxazine compound or salt thereof |
| 12/18/2013 | CN103459396A [1, 2, 4] triazolo [4, 3 -b] pyridazine compounds as inhibitors of c-met tyrosine kinase |
| 12/18/2013 | CN103459392A Process for the production of a pemetrexed salt |
| 12/18/2013 | CN103459388A Novel furanone derivative |
| 12/18/2013 | CN103459382A Heterocyclic compounds for the inhibition of pask |
| 12/18/2013 | CN103459373A Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds |
| 12/18/2013 | CN103459361A 1,5-diphenyl-penta-1,4-dien-3-one compounds |
| 12/18/2013 | CN103458930A Human antibodies and antibody-drug conjugates against CD74 |
| 12/18/2013 | CN103458918A Pegylated human HDL particle and process for production thereof |
| 12/18/2013 | CN103458902A Therapeutic use of a tlr agonist and combination therapy |
| 12/18/2013 | CN103458896A Methods for treating cancer |
| 12/18/2013 | CN103458881A Methods of using ALK inhibitors |
| 12/18/2013 | CN103451246A Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
| 12/18/2013 | CN103451155A Applications of miR-199*-carried mesenchymal stem cells in hepatoma carcinoma cell therapy, and construction method of miR-199*-carried mesenchymal stem cells |
| 12/18/2013 | CN103451152A Application of adipose-derived mesenchymal stem cells in preparation of liver cancer chemosensitization preparation |
| 12/18/2013 | CN103451071A Production method of anti-cancer health tea wine |
| 12/18/2013 | CN103450483A Random copolymer based on polyphosphoester as well as preparation method and application thereof |
| 12/18/2013 | CN103450361A Carboxymethyl cellulose grafted polylactic acid amphiphilic polymer, as well as preparation method and application thereof |
| 12/18/2013 | CN103450360A Antibodies to cd40 |
| 12/18/2013 | CN103450340A Heterocyclic carboxylic acid-modified anti-tumor oligopeptides and their synthesis, anti-tumor effects and application |
| 12/18/2013 | CN103450338A Heterocyclic carboxylic acid-modified thymopentins and their preparation method, anti-tumor effect and use |
| 12/18/2013 | CN103450335A Beta-carboline acyl tryptophyl tryptophan amino acid benzyl ester, as well as synthesis, anti-tumor action and application thereof |
| 12/18/2013 | CN103450332A Styrene-beta-carboline-modified tripeptide benzyl ester, as well as preparation, anti-tumor activity and application thereof |
| 12/18/2013 | CN103450329A 3H-imidazo[4,5-c]pyridine-6-formyl-amido acid benzyl esters and their synthesis, anti-tumor activity and use |
| 12/18/2013 | CN103450321A Nortriterpene compound as well asand preparation method and application thereof |
| 12/18/2013 | CN103450314A Plant extract with anti-tumor activity and active ingredients thereof |
| 12/18/2013 | CN103450310A Stigmasterol derivative and application thereof in preparation of anti-cancer drug |
| 12/18/2013 | CN103450304A Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives |
| 12/18/2013 | CN103450301A Farnesyl thiosalicylic acid-nucleoside conjugate as well as preparation method and medical application thereof |
| 12/18/2013 | CN103450290A Feruloyl oligosaccharides and preparation method and application thereof |
| 12/18/2013 | CN103450282A Palladium complex with anti-cancer activity and preparation method thereof |
| 12/18/2013 | CN103450281A 1-azabenzanthrone-platinum (II) complex as well as synthesis method and application thereof |
| 12/18/2013 | CN103450253A Dibutyltin4-nitrobenzoate in trapezoid structure as well as preparation method and application thereof |
| 12/18/2013 | CN103450252A Dibutyltin alpha-naphthylacetate having tin-containing oxygen heterocyclic structure and preparation method and application thereof |
| 12/18/2013 | CN103450241A Borate compound and medicine composition thereof |
| 12/18/2013 | CN103450236A 6-Hydroxyloxoisoaporphine rare earth complexes, and synthetic method and application thereof |
| 12/18/2013 | CN103450221A Alpha helix mimetics and methods relating thereto |
| 12/18/2013 | CN103450218A Indole tricyclic derivative as CRTH2 receptor antagonist |
| 12/18/2013 | CN103450204A Pyrrole [2,1-f][1,2,4] triazine compound, and preparation method and purpose thereof |
| 12/18/2013 | CN103450199A Theanine-modified carboline acyl amino acid benzyl ester, as well as preparation, anti-tumor activity and application thereof |
| 12/18/2013 | CN103450198A Imidazo pyrido imidazole-3-substituted benzyl acetates, and synthesis, antineoplastic activities and application thereof |
| 12/18/2013 | CN103450181A Medical application of 2-[4-(quinoxaline-2-oxy)phenoxy]amide |
| 12/18/2013 | CN103450180A Medical application of 2-[4-(benzoxazole-2-oxy)phenoxy]amide |
| 12/18/2013 | CN103450176A Naphthalimide compound containing 2-(4-aminophenyl) benzothiazole and application thereof |
| 12/18/2013 | CN103450175A Conjugated dienes derivative and preparation method thereof and application as anti-cancer drug |
| 12/18/2013 | CN103450171A Novel immune adjustment compound, application thereof and medicine combination comprising same |
| 12/18/2013 | CN103450167A Acylhydrazone derivatives containing 1, 3, 4-oxadiazole and pyrazine ring and preparation method and uses thereof |
| 12/18/2013 | CN103450165A 2,3-dehydrosilybin derivative, and preparation method and use thereof |
| 12/18/2013 | CN103450164A Geldanamycin derivatives as well as preparation methods and uses thereof |
| 12/18/2013 | CN103450152A Anti-tumor medicine in double-aryl urea structure based on indazole, indole, azaindazole or azaindole |
| 12/18/2013 | CN103450149A Phenylthiophene sulfonamides, and preparation methods and uses thereof |
| 12/18/2013 | CN103450133A Scopoletin derivatives with anti-tumor activity, and preparation method and application thereof |
| 12/18/2013 | CN103450112A N-bridge connected nitrogenous five-membered heterocyclic compound and preparation and application thereof |
| 12/18/2013 | CN103450099A Anastrozole, novel crystal form of monohydrate of anastrozole as well as preparation methods and application of novel crystal form |
| 12/18/2013 | CN103450096A Two nitrogen mustard derivatives, as well as preparation method and application therefore in tumor treatment |
| 12/18/2013 | CN103450093A 2-aminobenzimidazoles and applications thereof |
| 12/18/2013 | CN103450083A Geldanamycin derivatives and preparation method and applications thereof |
| 12/18/2013 | CN103450077A IRE-1A inhibitors |
| 12/18/2013 | CN103450062A Double-target point medicine compound for treating tumors as well as preparation method and application thereof |
| 12/18/2013 | CN103449524A Molybdenum oxide based nano photothermal conversion material and preparation method thereof |
| 12/18/2013 | CN103446588A Targeted diagnosis and treatment combined medicine and preparation method and applications thereof |
| 12/18/2013 | CN103446586A Application of dihydrogen porphin titanium complex in preparation of drug for treating tumor |
| 12/18/2013 | CN103446585A Method for ProNGF assay for in vitro diagnosis of cancer in particular breast, thyroid and lung cancer and therapeutic use of ProNGF |
| 12/18/2013 | CN103446580A Tumor vaccine and preparation method thereof |
| 12/18/2013 | CN103446557A Traditional Chinese medicine for treating hysteromyoma |
| 12/18/2013 | CN103446550A Traditional Chinese medicine preparation for treating cancers |